Current News

Contact | Print version | Send article | RSS feed

Orion Genomics and University of Glasgow Collaborate to Identify Epigenetic Biomarkers

24 Jan 2006 - Orion Genomics announced that it has initiated a collaboration with leading researchers at University of Glasgow to discover novel epigenetic biomarkers for the development of tests that screen for cancer at an early stage and provide personalized information about how tumors are most effectively treated. Under the collaboration, scientists at Orion and the University of Glasgow will use Orion's methylation technologies to identify biomarkers useful in the detection and treatment of cancers of the lung, breast and ovaries.
 
The groups will compare patterns of DNA methylation from normal and tumor DNA to identify specific patterns of abnormal methylation that indicate the presence of cancer and provide information about its stage and type. Orion will develop novel diagnostics based on these patterns that detect trace amounts of methylated tumor DNA in easily accessed patient samples including blood serum, biopsies, and cell scrapes.